Drugs and lungs – liaisons dangereuses webinar series

Educating healthcare professionals and researchers about drug-induced and iatrogenic respiratory diseases (DIRD) fosters a better understanding of the underlying mechanisms, risk factors, and potential management strategies. It helps them to understand the relationship between drugs and lung health, the risks associated with drug use and how to prevent drug-related lung diseases.

The Drugs and lungs – liaisons dangereuses webinar series is a seven-part programme that will take place from 26 June 2023 to 29 April 2024.

Educational aims

This webinar series aim to help participants develop a better understanding of the relationship between drugs and lungs. This knowledge can help them identify the signs and symptoms of drug-induced lung diseases (DILD) and provide appropriate care to patients.

Topics

• DILD Toolbox and essentials to start with
• DILD in interstitial lung diseases
• DILD in cancer treatment
• Drug-associated pulmonary arterial hypertension (PAH)
• DILD and systemic diseases

Learning outcomes

Following these seven webinars, participants will be able to:

• Recognise the impact of drug-induced diseases on lung health.
• Identify the different types of drugs that can cause lung disease.
• Understand the mechanisms by which drugs affect lung health and the impact of drug use on lung function.
• Recognise the signs and symptoms of respiratory problems related to medications.
• Optimise treatment by choosing alternative medications that are less likely to cause respiratory side effects.

Format and schedule

Each of the seven webinars will cover different aspects of drug-induced or iatrogenic respiratory diseases.

• Session one: Drug-induced lung diseases (DILD) – Toolbox and essentials to start with
• Session two: Interstitial lung diseases – Inflammation, fibrosis and oedema
• Session three: Interstitial lung diseases – Drugs and chemicals
• Session four: DILD in cancer treatment
• Session five: Drug-associated pulmonary arterial hypertension (PAH)
• Session six: DILD and systemic diseases
• Session seven: Respiratory injury from illicit drugs and substances

Check the Programme tab for more details regarding each session.

CME credits

An application will be submitted to the European Board for Accreditation in Pneumology (EBAP) for CME accreditation of this event. The number of credits that you will receive will correspond to the time you spend viewing the sessions live.

Recordings

Video recordings of each session will be made available to registered participants within two weeks of each session.

Register now

Below you can register for each session individually or benefit from reduced fees by registering for multiple sessions or the full series.